Free Trial

Bluejay Diagnostics (BJDX) Competitors

Bluejay Diagnostics logo
$1.41 -0.05 (-3.42%)
Closing price 04:00 PM Eastern
Extended Trading
$1.41 +0.00 (+0.28%)
As of 07:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BJDX vs. HSCS, STSS, SSKN, HSDT, LUCY, AMIX, GCTK, NUWE, XAGE, and QNRX

Should you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include HeartSciences (HSCS), Sharps Technology (STSS), Strata Skin Sciences (SSKN), Helius Medical Technologies (HSDT), Innovative Eyewear (LUCY), Autonomix Medical (AMIX), GlucoTrack (GCTK), Nuwellis (NUWE), Longevity Health (XAGE), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry.

Bluejay Diagnostics vs. Its Competitors

Bluejay Diagnostics (NASDAQ:BJDX) and HeartSciences (NASDAQ:HSCS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

In the previous week, Bluejay Diagnostics had 1 more articles in the media than HeartSciences. MarketBeat recorded 2 mentions for Bluejay Diagnostics and 1 mentions for HeartSciences. Bluejay Diagnostics' average media sentiment score of -1.00 equaled HeartSciences'average media sentiment score.

Company Overall Sentiment
Bluejay Diagnostics Negative
HeartSciences Negative

Bluejay Diagnostics has higher revenue and earnings than HeartSciences. HeartSciences is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Bluejay Diagnostics$250K8.40-$7.72M-$125.15-0.01
HeartSciencesN/AN/A-$8.77M-$9.36-0.36

Bluejay Diagnostics has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Comparatively, HeartSciences has a beta of 2.57, meaning that its share price is 157% more volatile than the S&P 500.

18.5% of Bluejay Diagnostics shares are held by institutional investors. Comparatively, 17.2% of HeartSciences shares are held by institutional investors. 0.1% of Bluejay Diagnostics shares are held by company insiders. Comparatively, 1.8% of HeartSciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

HeartSciences' return on equity of -293.60% beat Bluejay Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Bluejay DiagnosticsN/A -362.07% -299.10%
HeartSciences N/A -293.60%-135.39%

HeartSciences has a consensus price target of $13.00, suggesting a potential upside of 290.39%. Given HeartSciences' stronger consensus rating and higher possible upside, analysts clearly believe HeartSciences is more favorable than Bluejay Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bluejay Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
HeartSciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

HeartSciences beats Bluejay Diagnostics on 8 of the 13 factors compared between the two stocks.

Get Bluejay Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BJDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BJDX vs. The Competition

MetricBluejay DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$2.18M$6.90B$5.75B$9.85B
Dividend YieldN/A1.22%6.67%4.51%
P/E Ratio-0.0126.0678.4326.42
Price / Sales8.4070.07546.94119.09
Price / CashN/A21.6037.0558.92
Price / Book0.144.9010.916.06
Net Income-$7.72M$178.27M$3.29B$266.28M
7 Day Performance2.92%-0.61%0.01%-0.76%
1 Month Performance-5.69%1.88%7.06%3.83%
1 Year Performance-81.81%9.93%50.09%24.39%

Bluejay Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BJDX
Bluejay Diagnostics
0.2385 of 5 stars
$1.41
-3.4%
N/A-82.0%$2.18M$250K-0.019News Coverage
Negative News
Short Interest ↑
Gap Down
HSCS
HeartSciences
2.1806 of 5 stars
$3.35
-8.2%
$13.00
+288.1%
+6.5%$8.31MN/A-0.3610Upcoming Earnings
Short Interest ↑
STSS
Sharps Technology
0.8461 of 5 stars
$10.35
+40.6%
N/AN/A$7.53MN/A-0.013Short Interest ↑
Gap Up
High Trading Volume
SSKN
Strata Skin Sciences
3.4085 of 5 stars
$1.73
-1.1%
$6.00
+246.8%
-40.7%$7.30M$33.56M-0.61120News Coverage
Gap Down
HSDT
Helius Medical Technologies
1.0613 of 5 stars
$6.22
-2.5%
N/A-99.1%$6.87M$295K0.0030Positive News
Short Interest ↓
LUCY
Innovative Eyewear
N/A$1.98
-0.5%
N/A-57.8%$6.56M$1.64M-0.719Gap Down
AMIX
Autonomix Medical
3.1633 of 5 stars
$1.02
+1.0%
$16.50
+1,517.6%
-91.9%$5.20MN/A-0.181News Coverage
Short Interest ↓
Gap Down
GCTK
GlucoTrack
1.2685 of 5 stars
$4.87
-11.9%
N/A-99.8%$4.97MN/A-0.095Short Interest ↓
High Trading Volume
NUWE
Nuwellis
2.2803 of 5 stars
$5.28
+1.1%
N/A-91.0%$4.71M$8.74M-0.1570Positive News
Short Interest ↓
Gap Down
XAGE
Longevity Health
N/A$2.70
+3.4%
N/AN/A$4.65M$50K0.0014
QNRX
Quoin Pharmaceuticals
1.328 of 5 stars
$7.40
+2.8%
N/A-67.5%$4.24MN/A-0.184Short Interest ↓

Related Companies and Tools


This page (NASDAQ:BJDX) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners